e-short communication

Wednesday, 23 November

09:00

PREPARDNESS in Europe. How are European countries prepared for current and future drug developments?

09:00 to 19:30

Digital kiosks

John-Peter Kools

e-short communication

Improving drug treatment in prison: Policy recommendations by key stakeholders

09:00 to 19:30

Digital kiosks

Marjolein De Pau

e-short communication

Technology-assisted buprenorphine treatment for rural patients with opioid use disorder (OUD)

09:00 to 19:30

Digital kiosks

Stacey Sigmon

e-short communication

Beyond patientism: Users’ organizations deployment of an auxiliary welfare system in Norway

09:00 to 19:30

Digital kiosks

Isa Dussauge

e-short communication

Keeping kids safe these days: a case study of the health and well-being related perceptions and experiences of school-aged children who live in areas of urban disadvantage in Ireland.

09:00 to 19:30

Digital kiosks

Eleanor Hollywood

e-short communication

How will the legal cannabis industry affect the use and sale of alcohol, tobacco and medicines?

09:00 to 19:30

Digital kiosks

Marthe Ongenaert

e-short communication

A scoping review of social network analysis in drugs research

09:00 to 19:30

Digital kiosks

Naomi Zakimi

e-short communication

The impact of Covid-19 Pandemic on the everyday life of an open therapeutic program for drug-addicted individuals

09:00 to 19:30

Digital kiosks

Stelios Gkiouzepas

e-short communication

Psychoactive substance use among residents of long-term care facilities for the elderly: a review of the literature on innovative practices

09:00 to 19:30

Digital kiosks

Camille Beaujoin

e-short communication

The experience of being released from jail: A case study

09:00 to 19:30

Digital kiosks

Daisy Gibbs

e-short communication

Implications of the COVID-19 pandemic to problematic drug use and Harm Reduction responses in Porto and Lisbon - a comparative analysis

09:00 to 19:30

Digital kiosks

Cristiana Vale Pires

e-short communication

‘LOVE MY LUNGS’ - A SMOKE-FREE HOME INTERVENTION FOR FAMILIES OF BABIES ADMITTED TO NEONATAL INTENSIVE CARE

09:00 to 19:30

Digital kiosks

Caitlin Notley

e-short communication

Empathy, Evidence and Experience: Learning from overseas to respond to street-based drug injecting in Dublin City Centre.

09:00 to 19:30

Digital kiosks

Tony Duffin

e-short communication

Profile of substance use, psychopathology and quality of life amid SARS-CoV-2 pandemic in the population of homeless drug users living in a transitional guesthouse: a cohort study

09:00 to 19:30

Digital kiosks

Christina Tsatsaroni Syrgkani

e-short communication

Relationship between emotion regulation strategies and resilient coping of inmates

09:00 to 19:30

Digital kiosks

Isabel Silva

Thursday, 24 November

09:00

e-short communication

A descriptive comparison of substance use characteristics, psychosocial and socioeconomic problems among boys and girls entering a long-term residential substance use treatment institution in Norway. Preliminary results.

09:00 to 19:30

Digital kiosks

Regine Bakken

e-short communication

Reductions in prescribing following legislative intervention to make gabapentin a controlled substance at the state level in the U.S.

09:00 to 19:30

Digital kiosks

Mance Buttram

e-short communication

The response of low-threshold organizations in the field of drugs and homelessness during Covid-19 in Slovenia

09:00 to 19:30

Digital kiosks

Ines Kvaternik

e-short communication

Exploring mental health versus specialized addiction services: who chooses what? An analysis of the Belgian treatment demand register

09:00 to 19:30

Digital kiosks

Kim Fernandez

e-short communication

Infralow neurofeedback in the treatment of substance use disorders: A randomized controlled trial

09:00 to 19:30

Digital kiosks

Karin Berle Gabrielsen

e-short communication

Scratching the surface: National implementation and early evaluation of self-care wound pack provision to prevent bacterial infections in people who inject drugs.

09:00 to 19:30

Digital kiosks

Michelle Hughes

e-short communication

Drug Decriminalization as a Response to Overdose in the United States

09:00 to 19:30

Digital kiosks

Ricky Gunawan

e-short communication

Development and upgrade of mobile units for the implementation of preventive programmes and harm reduction programmes in the field of illicit drugs

09:00 to 19:30

Digital kiosks

Jože Hren

e-short communication

The effects of substance use on the female population: A brief exploration

09:00 to 19:30

Digital kiosks

Sabrina de Jesus

e-short communication

Managing COVID-19 pandemic infection in the residential therapeutic community KETHEA ITHAKI: the view of TC members

09:00 to 19:30

Digital kiosks

Theodora Sizopoulou

e-short communication

Virtual relapse prevention group tele-therapy with peer involvement for substance use disorder: a multicentre randomised controlled trial in Indonesia

09:00 to 19:30

Digital kiosks

Chika Yamada

e-short communication

Improving the Addiction Treatment Workforce through a Structured Mentorship Program

09:00 to 19:30

Digital kiosks

Roger Peters

e-short communication

Exploring gender-specific in-patient treatment for substance use disorders in Norway

09:00 to 19:30

Digital kiosks

Hanne Lorimer Aamodt

Friday, 25 November

09:00

e-short communication

Integrative Couple Treatment for Addiction: A revised model based on forgiveness and attachment needs

09:00 to 14:50

Digital kiosks

Joël Tremblay

e-short communication

Positive Choices: Evaluation of a national initiative to disseminate evidence-based alcohol and other drug education and wellbeing resources

09:00 to 14:50

Digital kiosks

Emma K Devine

e-short communication

Supporting the central role of people with addiction problems in addressing their problems: the example of Self-Help Promotion Program in Greece

09:00 to 14:50

Digital kiosks

Sotiris Lainas

e-short communication

Is high-risk drug use increasing in Finland? The prevalence of high-risk amphetamine and opioid use in 2017.

09:00 to 14:50

Digital kiosks

Sanna Rönkä

e-short communication

Let’s End HepC: Patient advocacy for hepatitis C elimination in the prisoner’s population

09:00 to 14:50

Digital kiosks

Catarina Hermenegildo

e-short communication

Monitoring opioid agonist maintenance treatment outcomes for people who use opioids and public health

09:00 to 14:50

Digital kiosks

Lucas Wiessing

e-short communication

Substitution of illicit diazepam with etizolam within the United Kingdom drug market 2021 and service response

09:00 to 14:50

Digital kiosks

Dean Acreman

Presentations

PREPARDNESS in Europe. How are European countries prepared for current and future drug developments?

Improving drug treatment in prison: Policy recommendations by key stakeholders

Technology-assisted buprenorphine treatment for rural patients with opioid use disorder (OUD)

Beyond patientism: Users’ organizations deployment of an auxiliary welfare system in Norway

Keeping kids safe these days: a case study of the health and well-being related perceptions and experiences of school-aged children who live in areas of urban disadvantage in Ireland.

How will the legal cannabis industry affect the use and sale of alcohol, tobacco and medicines?

A scoping review of social network analysis in drugs research

The impact of Covid-19 Pandemic on the everyday life of an open therapeutic program for drug-addicted individuals

Psychoactive substance use among residents of long-term care facilities for the elderly: a review of the literature on innovative practices

The experience of being released from jail: A case study

Implications of the COVID-19 pandemic to problematic drug use and Harm Reduction responses in Porto and Lisbon - a comparative analysis

‘LOVE MY LUNGS’ - A SMOKE-FREE HOME INTERVENTION FOR FAMILIES OF BABIES ADMITTED TO NEONATAL INTENSIVE CARE

Empathy, Evidence and Experience: Learning from overseas to respond to street-based drug injecting in Dublin City Centre.

Profile of substance use, psychopathology and quality of life amid SARS-CoV-2 pandemic in the population of homeless drug users living in a transitional guesthouse: a cohort study

Relationship between emotion regulation strategies and resilient coping of inmates

A descriptive comparison of substance use characteristics, psychosocial and socioeconomic problems among boys and girls entering a long-term residential substance use treatment institution in Norway. Preliminary results.

Reductions in prescribing following legislative intervention to make gabapentin a controlled substance at the state level in the U.S.

The response of low-threshold organizations in the field of drugs and homelessness during Covid-19 in Slovenia

Exploring mental health versus specialized addiction services: who chooses what? An analysis of the Belgian treatment demand register

Infralow neurofeedback in the treatment of substance use disorders: A randomized controlled trial

Scratching the surface: National implementation and early evaluation of self-care wound pack provision to prevent bacterial infections in people who inject drugs.

Drug Decriminalization as a Response to Overdose in the United States

Development and upgrade of mobile units for the implementation of preventive programmes and harm reduction programmes in the field of illicit drugs

The effects of substance use on the female population: A brief exploration

Managing COVID-19 pandemic infection in the residential therapeutic community KETHEA ITHAKI: the view of TC members

Virtual relapse prevention group tele-therapy with peer involvement for substance use disorder: a multicentre randomised controlled trial in Indonesia

Improving the Addiction Treatment Workforce through a Structured Mentorship Program

Exploring gender-specific in-patient treatment for substance use disorders in Norway

Integrative Couple Treatment for Addiction: A revised model based on forgiveness and attachment needs

Positive Choices: Evaluation of a national initiative to disseminate evidence-based alcohol and other drug education and wellbeing resources

Supporting the central role of people with addiction problems in addressing their problems: the example of Self-Help Promotion Program in Greece

Is high-risk drug use increasing in Finland? The prevalence of high-risk amphetamine and opioid use in 2017.

Let’s End HepC: Patient advocacy for hepatitis C elimination in the prisoner’s population

Monitoring opioid agonist maintenance treatment outcomes for people who use opioids and public health

Substitution of illicit diazepam with etizolam within the United Kingdom drug market 2021 and service response